Đang chuẩn bị liên kết để tải về tài liệu:
Prognostic utility of soluble suppression of tumorigenicity 2 level as a predictor of clinical outcomes in incident hemodialysis patients

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The suppression of tumorigenicity 2 (ST2) is associated with cardiac remodeling and tissue fibrosis. It is well known as a novel biomarker on predictor of cardiovascular events in patients with heart failure. In patients needed to start dialysis treatment, most of them had congestive heart failure. | Prognostic utility of soluble suppression of tumorigenicity 2 level as a predictor of clinical outcomes in incident hemodialysis patients

TÀI LIỆU LIÊN QUAN

Diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease

Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: Evidence from a systematic meta-analysis

Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment

Báo cáo hóa học: " Prognostic utility of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI)"

Báo cáo khoa học: "Prognostic utility of RIFLE for acute renal failure in patients with sepsis"

Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma

The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: In-vitro discovery and in-vivo validation

Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma

Prognostic utility of soluble suppression of tumorigenicity 2 level as a predictor of clinical outcomes in incident hemodialysis patients

Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation